New Delhi, March 11 The fair trade regulator, CCI, has approved Temasek Holdings' proposal to acquire a stake in Curefit Healthcare, the sovereign wealth fund.
Temasek Holdings, based in Singapore, is acquiring the stake through its affiliate, MacRitchie Investments Pte Ltd.
"The proposed transaction involves the additional acquisition of a certain stake by the acquirer in the target, to supplement the target's capital requirements in the fitness sector," CCI said in a statement on Wednesday.
Curefit Healthcare is the ultimate parent entity of the Curefit Healthcare Group. It operates in India, providing fitness management programs, the operation and franchising of fitness centers, and the sale of fitness apparel, footwear, and accessories.
"The Commission approves the acquisition of a certain stake in Curefit Healthcare Private Limited (Target) by MacRitchie Investments Pte Ltd (Acquirer)," the regulator added.
Temasek, a global investment company, has a diverse portfolio that includes industries such as transportation, financial services, telecommunications, media & technology, consumer & real estate, as well as life sciences & agri-food.
As of March 31, 2025, Temasek has a portfolio worth 434 billion Singapore dollars, primarily in Singapore and the rest of Asia.
In a separate statement on Wednesday, the Competition Commission of India (CCI) has cleared the proposed acquisition by Cube V of the road asset businesses of DYIPL, DVIPL, DGIPL, and DTEHPL.
Cube Highways and Infrastructure V Pte Ltd (Cube V) is a Sebi-registered foreign portfolio investor. It acquires, operates, and manages road assets in India.
DYIPL, DVIPL, DGIPL, and DTEHPL are all companies that operate roads and highways in India.
Deals exceeding a certain threshold require approval from the regulator, which monitors unfair business practices and promotes fair competition in the marketplace.
